New Zealand markets open in 45 minutes

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
188.53-0.27 (-0.14%)
At close: 1:00PM EST
185.00 -3.53 (-1.87%)
After hours: 04:53PM EST
Full screen
Trade prices are not sourced from all markets
Previous close188.80
Open188.80
Bid184.32 x 1000
Ask199.50 x 1200
Day's range185.65 - 192.60
52-week range121.98 - 212.00
Volume340,765
Avg. volume604,800
Market cap22.548B
Beta (5Y monthly)0.96
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    Alnylam to Webcast Presentations at Upcoming Investor Conferences

    CAMBRIDGE, Mass., November 23, 2021--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences being held virtually:

  • Business Wire

    Alnylam Presents New Data for Zilebesiran, an Investigational RNAi Therapeutic for the Treatment of Hypertension, at the American Heart Association Scientific Sessions 2021

    CAMBRIDGE, Mass., November 13, 2021--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced positive interim results from the ongoing Phase 1 study of zilebesiran (formerly known as ALN-AGT), an investigational subcutaneous RNAi therapeutic targeting liver-expressed angiotensinogen (AGT) in development for the treatment of hypertension. Findings on the pharmacodynamic and antihypertensive effects of zilebesiran six months after a single dose were pre

  • Business Wire

    Alnylam to Webcast Virtual R&D Day

    CAMBRIDGE, Mass., November 12, 2021--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will webcast its upcoming virtual R&D Day event on the Investors section of the Company’s website, www.alnylam.com, on November 19, 2021. The event will include presentations from Alnylam senior leaders as well as guest speakers.